Biotech

True Nature Holding, Inc. Updates Acquisition Plan

ATLANTA, GA: ...

Aldeyra Therapeutics Announces Positive Results from a Randomized, Double-Blind, Vehicle-Controlled Clinical Trial of Topical Dermatologic NS2 in Patients With Sjögren-Larsson Syndrome

LEXINGTON, MA: Data Demonstrate Superiority of NS2 over Vehicle in Achieving Clinically Meaningful Improvement All NS2-Treated Patients Demonstrated Improvement During Therapy Dermal Biomarker Changes Consistent wit ...

Aldeyra Therapeutics Schedules Conference Call to Present Results of a Randomized, Double-Blind, Vehicle-Controlled Clinical Trial in Sjogren-Larsson Syndrome

LEXINGTON, MA: ...

Flamel Technologies Reports Second Quarter 2016 Results

LYON, FRANCE: Total Revenues of $38.9 Million; 2016 Revenue Guidance Increased to $125 to $140 Million; Akovaz™ to Launch in August 2016 ...

Nerium Biotechnology Seeks Injunction Against Nerium International Japan G.K.

SAN ANTONIO, TEXAS: ...

Aldeyra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference

LEXINGTON, MA: ...

Medgenics Reports Second Quarter 2016 Financial Results

PHILADELPHIA, PA: ...

Aldeyra Therapeutics Schedules Webcast and Conference Call for Second Quarter 2016 Financial and Operating Updates

LEXINGTON, MA: ...

Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA: ...

Pacific Therapeutics Plans to Acquire Tower Three Wireless SAS

VANCOUVER, BRITISH COLUMBIA: ...